4,4,5,5-TETRAMETHYL-2-(10-PHENYLANTHRACEN-9-YL)-1,3,2-DIOXABOROLANE, 95.0%, 1g

2-(N-(2-METHOXYETHYL)-3,5-DIMETHYLISOXAZOLE-4-SULFONAMIDO)ACETIC ACID, 95.0%, 250mg

2-((S)-N-(2,3-Dihydro-1H-inden-2-yl)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanamido)acetic acid hydrochloride, 97%, 1g

(S)-3-Amino-3-(2-bromophenyl)propanoic acid, 95.0%, 1g

Methyl 2-chlorothiazole-5-carboxylate, 95.0%, 1g

6-(4-AMINO-4-METHYLPIPERIDIN-1-YL)-3-(2,3-DICHLOROPHENYL)PYRAZIN-2-AMINE, 95.0%, 250mg

5-(4-Methoxy-benzyl)-4-methyl-4H-[1,2,4]triazole-3-thiol, 5g

Methyl 3-Chloro-4-methylbenzoate>98.0%(GC)5g

5-Bromo-1-methyl-1H-1,2,3-triazole, 97%, 1g

Ranitidine>98.0%(HPLC)(T)5g

3-Bromo-5-methoxybenzene-1-sulfonyl chloride, 95%, 100mg

(2s,4r)-4-Fluoropyrrolidine-2-carboxamide hydrochloride, 95+%, 250mg

Ethyl 3-Bromo-6-chloroimidazo[1,2-a]pyridine-2-carboxylate, 97.0%, 1g